Assessing the inclusion of postinflammatory hyperpigmentation outcomes in acne vulgaris clinical trials - 01/11/24
Doi : 10.1016/j.jaad.2024.10.004
Alyssa Swearingen, BA a, b, Christine Olagun-Samuel, BA a, Arielle R. Nagler, MD a, Prince Adotama, MD a, ⁎ 
a Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New York
b Rutgers New Jersey Medical School, Newark, New Jersey
∗Correspondence to: Prince Adotama, MD, Ronald O. Perelman Department of Dermatology, NYU Langone Health, 240 E 38th St, 12th Floor, New York, NY 10016Ronald O. Perelman Department of DermatologyNYU Langone Health240 E 38th St, 12th FloorNew YorkNY10016
En prensa. Pruebas corregidas por el autor.
Disponible en línea desde el Friday 01 November 2024
This article has been published in an issue click here to access
This article has been published in an issue click here to access
Key words : acne-induced hyperpigmentation, acne vulgaris, clinical trials, outcome measures, postinflammatory hyperpigmentation, primary outcomes, secondary outcomes, skin of color
| Authors Swearingen and Olagun-Samuel contributed to this work equally. |
|
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2024
American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?